First Successful Haploidentical Stem Cell Transplantation in Romania

Tănase, Alina; Tomuleasa, C.; Mărculescu, Alexandra; Bardaş, A.; Coliţă, Anca; Ciurea, Ş.O.

doi:10.1515/rjim-2016-0021

Abstract

Hematopoietic stem cell transplantation is an established treatment for many malignant and non-malignant haematological disorders. In the current case report, we describe the first haploidentical stem cell transplantation, used for the first time in Romania, the case of a 33 year-old young woman diagnosed with Hodgkin’s lymphoma that has underwent a haploSCT after she relapsed from several chemotherapy regimens, as well as after an autologous stem cell transplantation. This success represents a prèmiere in Romanian clinical hematology, being the first case of a haploSCT in Romania, as well as in South-Eastern Europe.

References

1. GYURKOCZA B., REZVANI A., STORB RF. Allogeneic hematopoietic cell transplantation: the state-of-the-art. Expert Rev Hematol. 2010; 3(3):285-99.10.1586/ehm.10.21294339320871781
Search in Google Scholar Back to article
2. BARON F., STORB R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.
Search in Google Scholar Back to article
Springer Semin Immunopathol. 2004; 26(1-2):71-94.10.1007/s00281-004-0165-315549304
Search in Google Scholar Back to article
3. BARONF., STORB R., LITTLE MT. Hematopoietic cell transplantation: five decades of progress. Arch Med Res. 2003; 34(6):528-44.10.1016/j.arcmed.2003.09.01014734093
Search in Google Scholar Back to article
4. STAAL F.J., BAUM C., COWAN C., DZIERZAK E., HACEIN-BEY-ABINA S., KARLSSON S., et al. Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Leukemia. 2011; 25(7):1095-102.10.1038/leu.2011.5221527933
Search in Google Scholar Back to article
5. SAULNIER N., DI CAMPLI C., ZOCCO M.A., DI GIOCCHINNO G., NOVI M., GASPARRINI A. From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? Eur Rev Med Pharmacol Sci. 2005; 9(6):315-24.
Search in Google Scholar Back to article
6. CANELLOS G.P., ANDERSSON J.R., PROPERT K.J., NISSE N., COOPER M.R., HENDERSSON E.S., et al. Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992; 327(21):1478-84.10.1056/NEJM1992111932721021383821
Search in Google Scholar Back to article
7. DIEHL V., FRANKLIN J., PFEUNDSCHUCH M., LATHAN B., PAULUS U., HASENCLEVER D., et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease. N Engl J Med. 2003; 348(24):2386-95.10.1056/NEJMoa02247312802024
Search in Google Scholar Back to article
8. SANTORO A., MAGAGNOLI M., SPINA M., PINOTTI G., SIRACUSANO L., MICHIELI M., et al. Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin’s lymphoma. Haematologica. 2007; 92(1):35-41.10.3324/haematol.1066117229633
Search in Google Scholar Back to article
9. JOSTING A., RUDOLPH C., MAPARA M., GLOSSMANN J.P., SIENIAWSKI M., SIEBER M., et al. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol. 2005; 16(1):116-23.10.1093/annonc/mdi00315598948
Search in Google Scholar Back to article
10. GLOSSMANN J.P., STAAK J.O., NOGOVA L., DIEHL V., SCHEID C., KISRO J., et al. Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma. Ann Hematol. 2005; 84(8):517-25.10.1007/s00277-005-1011-y15759115
Search in Google Scholar Back to article
11. JOSTING A., NOGOVA L., FRANKLIN J., GLOSSMANN J.P., EICH H.T., SIEBER M., et al. Salvage radiotherapy in patients with relapsed and refractory Hodgkin’s lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J ClinOncol. 2005; 23(7):1522-9.10.1200/JCO.2005.05.02215632410
Search in Google Scholar Back to article
12. SELBY P., PATEL P., MILAN S., MELDRUM M., MANSI J., MBIDDE E., et al. ChlVPP combination chemotherapy for Hodgkin’s disease: long-term results. Br J Cancer. 1990; 62(2):279-85.10.1038/bjc.1990.278
Search in Google Scholar Back to article
13. POWLES R.L., MORGENSTERN G.R., KAY H.E., MCELWAIN T.J., CLINK H.M., DADY P.J.. et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet. 1983; 1(8325):612-5.10.1016/S0140-6736(83)91793-2
Search in Google Scholar Back to article
14. BEATTY P.G., CLIFT R.A., MICKELSON E.M., NISPEROS B.B., FLOURNOY N., MARTIN P.J., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985; 313(13):765-71.10.1056/NEJM1985092631313013897863
Search in Google Scholar Back to article
15. BRUNSTEIN C.G.,FUCHS E.J., CARTER S.L., KARANES C., COSTA L.J., WU J., et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011; 118(2):282-8.10.1182/blood-2011-03-344853313868321527516
Search in Google Scholar Back to article
16. AL MALKI M.M., HOROWITZ M., HANDGRETINGER R., LEUNG W., ROY D.C., HUANG X.J., et al. Proceedings from the Second Haploidentical Stem-cell Transplantation Symposium - Haplo2014, San Francisco, California, December 4, 2014. Biol Blood Marrow Transplant. 2016; S1083-8791(16)00004-5.10.1016/j.bbmt.2016.01.001710480526806585
Search in Google Scholar Back to article
17. KANATE A.S., MUSSETTI A., KHARFAN-DABAJA M.A., AHN K.W., DI GILIO A., BEITINJANEH A., et al. Reducedintensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors. Blood. 2016; in press.10.1182/blood-2015-09-671834476009426670632
Search in Google Scholar Back to article
18. BAYRAKTAR U.D., MILTON D.R., GUINDANI M., RONDON G., CHEN J., AL-ATRASH G., et al. Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation. Biol Blood Marrow Transplant. 2015; S1083-8791(15)00709-0.
Search in Google Scholar Back to article
19. BRAMMER J.E., KHOURI I., GABALLA S., ANDERLINI P., TOMULEASA C., AHMED S., et al. Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning. Biol Blood Marrow Transplant. 2015: S1083-8791(15)00685-0.
Search in Google Scholar Back to article
20. O’DONNEL P.V., LUZNIK L., JONES R.J., VOGELSANG G.B., LEFFEL M.S., PHELPS M., et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.Biol Blood Marrow Transplant. 2002; 8(7):377-86.10.1053/bbmt.2002.v8.pm1217148412171484
Search in Google Scholar Back to article
21. BASHEY A., ZHANG X., SIZEMORE C.A., MANION K., BROWN S., HOLLAND H.K., et al. T-cell-replete HLAhaploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31(10):1310-6.10.1200/JCO.2012.44.352323423745
Search in Google Scholar Back to article
22. DI STASI A., MILTON D.R., POON L.M., HAMDI A., RONDON G., CHEN J., et al. Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigenmatched unrelated and related donors. Biol Blood Marrow Transplant. 2014; 20(12):1975-81. 10.1016/j.bbmt.2014.08.013434320325263628
Search in Google Scholar Back to article

First Successful Haploidentical Stem Cell Transplantation in Romania

Abstract

Paradigm

My account